RSS

pancreatic cancer

A ground-breaking clinical trial is bringing a precision medicine approach to patients with pancreatic cancer for the first time in the UK. Read more

News

Nanobiotix, a late clinical-stage nanomedicine company, has started a pre-clinical collaboration with the Providence Cancer Institute to study NBTXR3 — a nanoparticle designed for direct injection into cancerous tumours and activation by radiotherapy Read more

News

An agreement has been formed between XBiotech and Cedars-Sinai Medical Center to perform a study evaluating the interleukin-1 alpha antagonist, MABp1, in combination with Onivyde and 5-fluorouracil/folinic acid to treat pancreatic cancer. Read more

News

UK-based independent drug discovery expert and research partner, Sygnature Discovery, and University College London (UCL) School of Pharmacy have formed a partnership for a £1 million pancreatic cancer research project. Read more

News

Clinical data from the Phase I/II trial of TG01 in resected pancreatic cancer will be presented at the American Society of Clinical Oncology (ASCO) meeting, announces Targovax. Read more

News

Clinical trial results of a new drug have shown positive data against fighting metastatic pancreatic cancer. Read more

News

The high-pressure environment of pancreatic cancer tumours are behind most drugs failing, according to researchers from the Fred Hutchinson Cancer Research Center Read more

News

Implantable device delivers treatment for pancreatic cancer directly to tumours, bypassing bloodstream and limiting widespread side effects, according to The University of North Carolina (UNC) Read more

News

The treatment market for pancreatic cancer is set to grow from its current level of £1.2bn ($1.9bn) to an impressive £1.9bn ($2.9bn) by 2021 Read more

News